ArticleCommunications biology2021

Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinity.

Ole A Mandrup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.